In aromatase inhibitor-resistant breast cancer cells, SREBP-1 can drive Keratin-80 upregulation to directly promote cytoskeletal rearrangements, cellular stiffening, and cell invasion (80). The gene discussed is SREBF1; the disease is breast carcinoma.